Search the Newsreel

Prothena Corporation PLC (PRTA) Institutional Confidence

Prothena Corporation PLC (PRTA) has an institutional shareholding score of 10.00, placing it first in the Biotechnology & Medical Research industry. Institutional shareholding stands at 96.24%, an increase of 19.52% quarter-over-quarter. James Simons is the largest institutional shareholder, holding 1.14% of shares outstanding.

Prothena Corporation PLC (PRTA) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Prothena Corporation PLC (PRTA), detailing its current risk score, beta value, and various volatility metrics. PRTA has a risk assessment score of 5.28, ranking 46 out of 386 in the Biotechnology & Medical Research industry, with a …

Prothena Corporation plc Revenue Breakdown – NASDAQ:PRTA

Prothena Corporation plc (NASDAQ: PRTA) generated $9.68 million USD in revenue last year. The majority of this, $9.63 million USD, came from its Collaboration segment, a decrease from $135.11 million USD the previous year. The United States was the company's primary revenue source.

Prothena stock trades steady as Alzheimer portfolio advances and earnings show growing R&D investmen

Prothena's stock reflects its focus on Alzheimer's and neurodegenerative diseases, with recent financial reports showing increased R&D spending and substantial cash reserves. While the company reported a net loss due to heavy R&D investment, its robust cash position of over $500 million provides a …

Trading the Move, Not the Narrative: (PRTA) Edition

Prothena Corporation Plc (NASDAQ: PRTA) is showing weak near and mid-term sentiment but maintains a strong long-term positive outlook. AI models have generated specific trading strategies with an exceptional 69.0:1 risk-reward setup, targeting a 16.4% gain against 0.2% risk. These strategies include position trading, …

PRTA Q1 2026 Earnings: Surprise Profit as EPS Beats Estimates by Wide Margin - Adjusted Earnings Analysis

Prothena Corporation (PRTA) Q1 2026 Earnings: Surprising Profitability Driven by Milestone Revenue, Stock Jumps 8%

PRTA Q1 2026 Earnings: Strong EPS Surprise Driven by Non-Operational Income - Pre-Announcement Alert

PRTA Q1 2026 Earnings: Surprise EPS Beat Driven by Milestone Revenue, Stock Edges Higher - Book Value Growth

Prothena (PRTA) Earnings Date and Reports 2026 $PRTA